A study conducted by Baptista-Hon et al. (97) found that, ropivacaine blocked the NaV1.5 VGSC of both neonatal and adult splice variants in colon cancer SW620 cells, with IC50 values of 2.5 and 3.9 μM, respectively. This evidence concerns the gene SCN5A and colonic neoplasm.